<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        70-171-10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2010
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DOLORAZ 100MG-5ML SUSPENSION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        IBUPROFEN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        4.7
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1055]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Dallah Health Care Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AE01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>DOLORAZ is the trademark of Ibuprofen, nonsteroidal anti-inflammatory agent (NSAIA).<br /><strong>INDICATIONS</strong><br />-DOLORAZ as analgesic is indicated to relieve pain such as: common cold, flu, sore throat, headache, migraine, toothache, low back pain, primary dysmenorrhea (period pain), and post operative pain, frozen shoulder (capsulitis), bursitis, tendonitis, tenosynovitis, in soft tissue injuries such as sprains and strains.<br />-DOLORAZ as antipyretic is used in fever conditions, particularly those associated with inflammation e.g. tonsillitis, follicular tonsillitis and otitis media.<br />-DOLORAZ is used to control signs and symptoms of pain due to rheumatoid arthritis (including juvenile rheumatoid arthritis or Still&#39;s disease), acute or chronic ankylosing spondylitis, osteoarthritis, psoriatic arthritis and other non-rheumatoid (seronegative) arthropathies.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>CONTRAINDICATIONS</strong><br />-Patients with a history of, or active, peptic ulceration.<br />-Patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis or urticaria) in response to Ibuprofen, aspirin or other NSAIDs. &nbsp;<br /><strong>WARNINGS</strong><br />-Caution is required if DOLORAZ is administered to patients suffering from, or with a previous history of, bronchial asthma. DOLORAZ should only be given with care to patients with a history of gastrointestinal disease. &nbsp;<br />-Caution is required in patients with renal, hepatic or cardiac impairment since the use of NSAIDs may result in deterioration of renal function. The dose should be kept as low as possible and renal function should be monitored in these patients. &nbsp;&nbsp;<br />-DOLORAZ should be given with care to patients with a history of heart failure or hypertension since oedema has been reported in association with Ibuprofen administration.&nbsp;<br />-Avoid concomitant use of two or more NSAIDs, acetaminophen or aspirin or other salicylates for more than a few days while receiving NSAID therapy, unless concurrent use is prescribed by, and patient remains under the care of, a physician or dentist.<br />-Avoid alcoholic beverages.&nbsp;</p><p><strong>PRECAUTIONS</strong></p><p><strong>-&nbsp;</strong>Monitoring of blood urea nitrogen (BUN), creatinine serum concentrations, and /or potassium serum concentrations may be required at periodic intervals during therapy, espescially in patients with documented hepatic or renal function impairment.</p><p>- Determination of hematocrit , hemoglobin and/or stool tests for occult blood loss may be preformed at one six month intervals to detect blood loss during prolonged therapy.</p><p><strong>USE IN PREGNANCY</strong><br />Although animal reproduction studies have not demonstrated any teratogenic effects, the safe use of Ibuprofen during pregnancy has not been established so, use of Ibuprofen is not recommended during pregnancy (especially during the last trimester) or during labor and delivery.&nbsp;<br /><strong>USE IN LACTATION</strong><br />Although Ibuprofen has not been reported to distribute into milk in lactating women, It is not recommended because of the potential risk of inhibitors of prostaglandin synthesis in neonates.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>DOSAGE</strong><br /><br /><u>Usual pediatric dose (6 months to 12 years of age)</u><br />Antirheumatic: initially 30 to 40 mg per kg of body weight a day in three or four divided doses, although 20 mg per kg of body weight per day may be sufficient for patients with mild disease. After a satisfactory response has been achieved, dosage should be reduced to the lowest dose needed to control disease activity.&nbsp;<br />Antipyretic: 5 mg per kg of body weight for fevers less than 39.17 &deg;C (102.5 &deg;F) and 10 mg per kg of body weight for higher fevers. Dosage may be repeated, if necessary, at intervals of 4 to 6 hours or more. This can be achieved as follows:&nbsp;<br />Infants 6-12 months: One 2.5 ml dose may be taken 3 to 4 times in 24 hours.&nbsp;<br />Children 1-3 years: One 5 ml dose may be taken 3 times in 24 hours.&nbsp;<br />Children 4-6 years: 7.5 ml (5 ml + 2.5ml spoonful) may be taken 3 times in 24 hours.&nbsp;<br />Children 7-9 years: Two 5 ml doses may be taken 3 times in 24 hours.&nbsp;<br />Children 10-12 years: Three 5 ml doses may be taken 3 times in 24 hours.&nbsp;<br /><strong>Notes</strong></p><p>-Infants up to 6 months of age: Safety and efficacy have not been established.&nbsp;<br />-In the treatment of arthritis, improvement in condition may occur within 7 days, but 1 to 2 weeks of continuous use on a regular basis may be required for maximum effectiveness.&nbsp;<br />-Preferably, take NSAIDs after meals or with food or antacids to reduce gastrointestinal irritation, especially during chronic use; however, for faster absorption when a rapid initial effect is required (as for analgesic or antipyretic use), the first 1 or 2 doses may be taken 30 minutes before meals or at least 2 hours after meals.&nbsp;</p><p><strong>OVERDOSE</strong><br />Symptoms include nausea, vomiting, dizziness and rarely loss of consciousness. Large overdoses are generally well tolerated when no other drugs are involved. Treatment consists of gastric lavage, administering activated charcoal and, if necessary, correction of serum electrolytes (Inducing diuresis may be helpful) and appropriate supportive measures. There is no specific antidote to Ibuprofen.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-Gastrointestinal: nausea, vomiting, diarrhoea, dyspepsia, abdominal pain, &nbsp;<br />-Hypersensitivity: anaphylaxis, respiratory tract reactivity or assorted skin disorders, including rashes, pruritus, urticaria, purpura, angioedema &nbsp;<br />-Cardiovascular: oedema.</p><p><strong>CARDIOVASCULAR RISK</strong><br />NSAIAs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk<br />NSAIAs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>store according to conditions specified on the package.</p><p>Do not use after the expiry date shown on the package.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>DOLORAZ is the trademark of Ibuprofen, nonsteroidal anti-inflammatory agent (NSAIA).<br />Each 5 ml of DOLORAZ &nbsp;Suspension contains 100 mg Ibuprofen.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                - Bottles of 100 ml of Doloraz suspension 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Jordanian Pharmaceutical Manufacturing CO (P.LC.)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                June 2007
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>دولوراز هو العلامة التجارية لايبوبروفين، وهو عامل لاستيرويدي مضاد للالتهاب<br /><strong>الاستطبابات&nbsp;</strong><br />&nbsp;يستطب دولوراز كمهدئ لازالة الألم مثل: الزكام، النزلة الوافدة، التهاب الحلق، صداع، الشقيقة، ألم في الاسنان، ألم في أسفل الظهر، عسر الطمث الأولي (ألم الدورة الشهرية)، ألم ما بعد العملية، منكب جمد (التهاب المحفظة)، التهاب الجراب، التهاب الوتر، التهاب غمد الوتر، اصابات الانسجة الطرية مثل الفكش والاجهاد<br />&nbsp;يستعمل دولوراز كمضاد للحمى في حالات الحمى وخاصة المرتبطة بالالتهاب مثل التهاب اللوزتين، التهاب اللوزتين الجريبي، التهاب الأذن الوسطى<br />&nbsp;يستعمل دولوراز للسيطرة على أعراض وعلامات الألم المتسببة من التهاب المفصل الرثياني (ويتضمن التهاب المفصل الريثاني الفتوي أو داء ستل)، التهاب الفقار الرثياني الحاد أو المزمن، فصال عظمي، التهاب المفصل الصدافي، اعتلالات مفصلية غير رثيانية أخرى سلبي المصل</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>مضادات الاستطباب</strong><br />المرضى الذين لهم سوابق مع التقرح الهضمي أو الفعال فيه<br />المرضى الذين أظهروا تفاعلات فرط الحساسية سابقاً (مثل الربو، التهاب الأنف أو الشرى) في الاستجابة لأيبوبروفين، أو الأسبرين أو الأدوية اللاستيرويدية المضادة للالتهاب<br /><strong>التحذيرات</strong><br />&nbsp;يجب أخذ الحذر إذا أعطي دولوراز للمرضى الذين يعانون أو لهم سوابق من الربو القصبي. &nbsp;يجب أن يعطى دولوراز بحذر فقط للمرضى الذين لهم سوابق مع المرض المعدي المعوي<br />&nbsp;يجب أخذ الحذر في المرضى المصابين بقصور كلوي أو كبدي أو قلبي لأن استخدام الأدوية اللاستيرويدية المضادة للالتهاب يمكن أن يسبب في تردي الوظيفة الكلوية. لذا يجب أن تبقى الجرعة أقل ما يمكن وأن تناطر الوظيفة الكلوية في هؤلاء المرضى<br />&nbsp;يجب أن يعطى دولوراز بحذر في المرضى الذين لهم سوابق مع قصور القلب أو ارتفاع ضغط الدم وذلك لأنه ورد أن الوذمة مرتبطة مع اعطاء الأيبوبروفين<br />&nbsp;تجنب الاستعمال المترافق لاثنين أو أكثر من الأدوية اللاستيرويدية المضادة للالتهاب، استيامينوفين أو اسبرين أو سالسيلات أخرى لأكثر من عدة &nbsp;أيام عند استقبال العلاج بالأدوية &nbsp;اللاستيرويدية المضادة للالتهاب، إلا إذا كان الاستعمال المترافق موصوف من قبل الطبيب أو طبيب الأسنان حيث يبقى المريض تحت اشرافهم<br />&nbsp;تجنب المشروبات الكحولية</p><p><strong>الاحتياطات</strong></p><p>&nbsp;يمكن أن يطلب مناطرة نيتروجين اليوريا في الدم، تراكيز مصل الكرياتينين، و/أو تراكيز مصل البوتاسيوم&nbsp;</p><p>بفترات دورية خلال العلاج و خاصة في المرضى المصابين بقصور ةظيفي للكلى أو الكبد</p><p>&nbsp;6 يمكن القيام بتحديد مكداس الدم الهيموغلوبين و أو اختبارات البراز لفقدان الدم الخفي من شهر إلى&nbsp;</p><p>أشهر للتحقق من فقدان الدم خلال العلاج المطول</p><p><strong>الاستعمال في حالة الحمل</strong><br />على الرغم من أن الدراسات التوالدية الحيوانية لم تظهر أي آثار ماسخة، إلا أن سلامة استعمال أيبوبروفين خلال الحمل لم تثبت، لذا لا ينصح باستعمال أيبوبروفين خلال الحمل (وخاصة خلال آخر ثلاثة شهور) أو خلال الوضع أو الولادة<br /><strong>الاستعمال في حالة الإرضاع</strong><br />على الرغم من أنه لم يرد تقارير بأن أيبوبروفين يتوزع في حليب الأم المرضعة، إلا أنه لا ينصح باستعماله وذلك بسبب الخطر الكامن لموانع تركيب البروستغلاندين في الولدان<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>الجرعة الاعتيادية للأطفال 6 أشهر إلى 12 سنة</strong><br />&nbsp;مضاد للرثية: الجرعة الابتدائية 30-40 ملغم/كغم من وزن الجسم مقسمة إلى 3-4 جرعات، وعلى الرغم من أن 20ملغم/ كغم من وزن الجسم باليوم يمكن أن تكون كافية للمرضى المصابين بأمراض خفيفة. وبعد الوصول إلى النتائج المرضية يجب أن تقلل الجرعة إلى أقل جرعة لازمة للسيطرة على فاعلية المرض<br />&nbsp;</p><p>مضاد للحمى: 5 ملغم/كغم من وزن الجسم للحمى التي أقل من 39.17 &deg;س (102.5 &deg;ف) و 10 ملغم/ كغم من وزن الجسم للحمى الأعلى. يمكن أن تكرر الجرعة، عند الضرورة، على فترات من 4-6 ساعات أو أكثر، ويمكن أن يتحقق ذلك كما يلي<br />الرضع 6-12 شهر: جرعة واحدة 2,5 ملل يمكن أن تؤخذ 3-4 مرات في 24 ساعة<br />الأطفال 1-3 سنوات: جرعة واحدة 5 ملل يمكن أن تؤخذ 3 مرات في 24 ساعة<br />الأطفال 4-6 سنوات: 7,5 ملل (5 ملل 2,5 + ملل ملء ملعقة) يمكن أن تؤخذ 3 مرات في 24 ساعة<br />الأطفال 7-9 سنوات: جرعتان 5 ملل يمكن أن تؤخذ 3 مرات في 24 ساعة<br />الأطفال 10-12 سنة: 3 جرعات 5 ملل يمكن أن يؤخذوا 3 مرات في 24 ساعة<br /><strong>ملاحظات</strong><br />&nbsp;الرضع حتى 6 أشهر من العمر: لم تثبت السلامة والفعالية بعد<br />&nbsp;في علاج التهاب المفاصل، يمكن أن تتحسن الحالة خلال 7 أيام ويمكن أن يحتاج أسبوع إلى أسبوعين من العلاج المستمر على أساس منتظم للفعالية القصوى<br />&nbsp;من المفضل أن تؤخذ الأدوية اللاستيرويدية المضادة للالتهابات بعد الوجبات أو الطعام أو مضادات الحموضة للتقليل من التهيج المعوي المعدي، وخاصة خلال الاستعمال المزمن، ولكن للامتصاص الأسرع وعند الحاجة إلى تأثير ابتدائي سريع (كاستعماله كمسكن أو مضاد للحمى)، يمكن أن تؤخذ أول أو ثاني جرعة قبل 30 دقيقة من الوجبات أوبعد ساعتين على الأقل من الوجبات</p><p><strong>فرط الجرعة</strong><br />تتضمن أعراض فرط الجرعة: الغثيان، القياء، دوخة ونادراً فقدان الوعي. ويمكن تحمل فرط الجرعة العالي عادة عندما لا يكون هنالك دواء آخر مستخدم<br />ويتألف العلاج من غسل المعدة، اعطاء الفحم المفعل وعند الضرورة تعديل الكهارل في المصل (يمكن أن يكون تحريض ادرار البول مفيداً) والقياسات الداعمة المناسبة. لايوجد هناك درياق خاص لأيبوبروفين</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;المعدية المعوية: غثيان ، قياء، اسهال، عسر الهضم، ألم بطني<br />&nbsp;فرط الحساسية: تأق، تنشيط الجهاز التنفسي أو اضطرابات الجلد المنوعة ويتضمن الطفح، الحكة، الشرى، فرفرية، وذمة وعائية<br />&nbsp;القلبية الوعائية: وذمة</p><p><strong>الخطر القلبي الوعائي</strong><br />يمكن أن تسبب العوامل اللاستيرويدية المضادة للالتهاب زيادة في احتمالية الحوادث الخثارية القلبية الوعائية واحتشاء عضلة القلب والسكتة، والتي يمكن أن تكون مميتة. ويمكن أن يزيد احتمال هذا الخطر مع زيادة مدة الاستعمال. و يمكن أن تزداد احتمالية الخطر لدى المرضى الذين يعانون من أمراض قلبية وعائية أو من عوامل مؤهبة للأمراض القلبية الوعائية<br />تسبب العوامل اللاستيرويدية المضادة للالتهاب زيادة في احتمالية الآثار الجانبية المعديَة المعوية المتضمنة النزف والتقرح وثقب المعدة أو الأمعاء، و التي يمكن أن تكون مميتة. ويمكن أن تحدث هذه الأحداث في أي وقت خلال الاستعمال، وقد لا يصاحبها أعراض تحذيرية. هذا وتزيد احتمالية تعرض المرضى الكهول للأحداث المعدية المعوية الخطيرة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ حسب ظروف الحفظ المبينة على الغلاف</p><p>لا ينبغي استعمال الدواء بعد تاريخ انتهاء الصلاحية المبين على الغلاف</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>دولوراز هو العلامة التجارية لايبوبروفين، وهو عامل لاستيرويدي مضاد للالتهاب<br />كل 5 مل من معلق دولوراز يحتوي على 100ملغم أيبوبروفين</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            عبوات سعة 100 مل من معلق دولوراز
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الشركة الأردنية لإنتاج الأدوية المساهمة العامة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            حزيران 2007
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                DOLORAZ  400 mg Soft Gelatin Capsules
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ibuprofen 400 mg/Capsule

Inactive ingredients:

NO.	INGREDIENT	QUANTITY MG/CAP
Filling Solution 
1.		Polyethylene glycol 600 	417.6
2.		Potassium Hydroxide 50% solution	102.4
Shell
3.		Anidrisorb 85/70	164.4
4.		Gelatin 150 Bloom EP	286.4

      *For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oblong yellowish clear soft gelatin capsule, filled with colorless viscous liquid.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For the relief of mild to moderate pain including rheumatic and muscular pain, migraine (with or without aura), backache, headache, dental pain, dysmenorrhoea, feverishness and for the relief of symptoms of cold and influenza</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For oral administration and short-term use only.</p><p>&nbsp;</p><p>For all indications:</p><p>Adults, older people and children and adolescents between 12-18 years of age:&nbsp;&nbsp;</p><p>&nbsp;</p><p>If in children or adolescents between 12 -18 years of age, this medicinal product is required for more than 3 days, or if symptoms worsen, a doctor should be consulted.</p><p>&nbsp;</p><p>For adults aged 18 years or older, the lowest effective dose should be used for the shortest duration necessary to relieve symptoms and minimise undesirable effects (see section 4.4).&nbsp; The patient should consult a doctor if symptoms persist or worsen, or if the product is required for more than 10 days.</p><p>&nbsp;</p><p>One capsule up to three times per day as required. The respective dosing interval should be chosen in line with the observed symptoms and the maximum recommended daily dose. Doses should be given approximately every 6-8 hours, with a minimum interval of 4 hours between each dose. A total dose of 1200 mg of ibuprofen (3 capsules) should not be exceeded in any 24 hour period. The capsules should be taken with water.</p><p>&nbsp;</p><p>Not to be used for children under 12 years of age.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                •	Hypersensitivity to ibuprofen or any of the constituents in this product.
•	Ibuprofen is contraindicated in patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angiodema or urticaria) in response to aspirin or other non-steroidal anti-inflammatory drugs.
•	Active or previous peptic ulcer (two or more distinct episodes of proven ulceration or bleeding).
•	History of upper gastrointestinal bleeding or perforation, related to previous NSAID therapy.
•	Patients with severe hepatic failure, renal failure or severe heart failure (NYHA Class IV) (See section 4.4).
•	Use in last trimester of pregnancy (See section 4.6).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Caution is required in patients with certain conditions:</p><p>&bull; Systemic lupus erythematosus as well as those with mixed connective tissue disease due to increased risk of aseptic meningitis (see Section 4.8)</p><p>&bull; Gastrointestinal disorders and chronic inflammatory intestinal disease as these conditions may be exacerbated (ulcerative colitis, Crohn&#39;s disease) (see Section 4.8)</p><p>&bull; Caution is required prior to starting treatment in patients with a history of hypertension and/or heart failure. Oedema, hypertension and/or cardiac impairment as renal function may deteriorate and/or fluid retention occur (see Section 4.8)</p><p>&bull; Renal impairment as renal function may deteriorate (see Section 4.3 and 4.8)</p><p>&bull; Hepatic dysfunction (see 4.3 and 4.8)</p><p>&nbsp;</p><p>Undesirable effects may be minimised by using the minimum effective dose for the shortest possible duration necessary to control symptoms. (See GI and cardiovascular risks below).</p><p>&nbsp;</p><p>The elderly are at increased risk of the serious consequences of adverse reactions.</p><p>&nbsp;</p><p>Bronchospasm may be precipitated in patients suffering from or with a previous history of bronchial asthma or allergic disease.</p><p>&nbsp;</p><p>Use with concomitant NSAIDs including cyclooxygenase-2 selective inhibitors should be avoided (see section 4.5).</p><p>&nbsp;</p><p><strong>Cardiovascular and cerebrovascular effects</strong></p><p>Clinical studies suggest that use of ibuprofen, particularly at high doses (2400 mg/day) may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke). Overall, epidemiological studies do not suggest that low dose ibuprofen (e.g. &le; 1200 mg daily) is associated with an increased risk of arterial thrombotic events.</p><p>Patients with uncontrolled hypertension, congestive heart failure (NYHA II-III), established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with ibuprofen after careful consideration and high doses (2400 mg/day) should be avoided.</p><p>Careful consideration should also be exercised before initiating long-term treatment of patients with risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking), particularly if high doses of ibuprofen (2400 mg/day) are required.</p><p>&nbsp;</p><p>There is some evidence that drugs which inhibit cyclooxygenase/prostaglandin synthesis, may cause impairment of female fertility by an effect on ovulation. This is reversible upon withdrawal of treatment.</p><p>&nbsp;</p><p>GI bleeding, ulceration and perforation, which can be fatal, has been reported with all NSAIDs at any time during treatment, with or without warning symptoms or a previous history of serious GI events (including ulcerative colitis, Crohn&#39;s disease).</p><p>&nbsp;</p><p>The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses, in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation (see section 4.3), and in the elderly. These patients should commence treatment on the lowest dose available.</p><p>&nbsp;</p><p>Patients with a history of GI toxicity, particularly the elderly, should report any unusual abdominal symptoms (especially GI bleeding) particularly in the initial stages of treatment.</p><p>&nbsp;</p><p>Caution should be advised in patients receiving concomitant medications which could increase the risk of gastrotoxicity or bleeding, such as corticosteroids, or anticoagulants such as warfarin, selective serotonin re-uptake inhibitors or anti-platelet agents such as aspirin (see Section 4.5).</p><p>Where GI bleeding or ulceration occurs in patients receiving ibuprofen, the treatment should be withdrawn immediately.</p><p>&nbsp;</p><p>Dermatological:</p><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDSs (see section 4.8). Patients appear to be at highest risk for these reactions early in the course of therapy: the onset of the reaction occurring in the majority of cases within the first month of treatment. Ibuprofen should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity.</p><p>&nbsp;</p><p>Patients with rare hereditary problems of fructose intolerance should not take this medicine. This medicine contains 40mg of potassium per dose. To be taken into consideration by patients with reduced kidney function or patients on a controlled potassium diet.</p><p>&nbsp;</p><p>There is a risk of renal impairment in dehydrated children and adolescents, between the ages of 12-18 year olds.</p><p>&nbsp;</p><p><strong>The label will include:</strong></p><p>&nbsp;</p><p>12-18 years: if symptoms worsen, or persist for more than 3 days, or you get new symptoms consult your doctor.</p><p>&nbsp;</p><p>Adults: if symptoms worsen, or persist for more than 10 days, or you get new symptoms consult your pharmacist or doctor.</p><p>Read the enclosed leaflet before taking this product.</p><p>&nbsp;</p><p>Do not take if you:</p><p>&bull; Have ever had a stomach ulcer, perforation or bleeding</p><p>&bull; Are allergic to ibuprofen (or anything else in this medicine), aspirin or other related painkillers</p><p>&bull; Are taking other NSAID painkillers, or aspirin with a daily dose above 75mg</p><p>&bull; Are in the last 3 months of pregnancy.</p><p>Speak to a pharmacist or your doctor before taking if you:</p><p>&bull; Have asthma, diabetes, high cholesterol, high blood pressure, had a stroke, heart, liver, kidney or bowel problems</p><p>&bull; Are a smoker</p><p>&bull; Are pregnant</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Ibuprofen should not be used in combination with:</strong></p><p><u>Acetylsalicylic acid</u></p><p>Concomitant administration of ibuprofen and aspirin (acetylsalicylic acid) is not generally recommended (unless low-dose aspirin (not above 75mg daily) has been advised by a doctor), as this combination may increase the risk of adverse reactions (see Section 4.4).</p><p>Experimental data suggest that ibuprofen may competitively inhibit the effect of low dose aspirin (acetylsalicylic acid) on platelet aggregation when they are dosed concomitantly. Although there are uncertainties regarding extrapolation of these data to the clinical situation, the possibility that regular, long-term use of ibuprofen may reduce the cardioprotective effect of low dose aspirin (acetylsalicylic acid) cannot be excluded. No clinically relevant effect is considered to be likely for occasional ibuprofen use (see section 5.1).</p><p>Other NSAIDs including cyclooxygenase-2 selective inhibitors, as these may increase the risk of adverse effects (see Section 4.4).</p><p><strong>&nbsp;</strong></p><p><strong>Ibuprofen should be used with caution in combination with:</strong></p><ul><li>Corticosteroids: May increase the risk of adverse reactions, especially of the gastrointestinal tract (see Section 4.4).</li><li>Antihypertensives and diuretics: NSAIDs may diminish the effect of these drugs. Diuretics can increase the risk of nephrotoxicity of NSAIDs.</li><li>Anticoagulants: NSAIDs may enhance the effects of anti-coagulants, such as warfarin (see Section 4.4.)</li><li>Anti-platelet agents and selective serotonin reuptake inhibitors (SSRIs): increased risk of gastrointestinal bleeding (see section 4.4)</li><li>Cardiac glycosides: NSAIDs may exacerbate cardiac failure, reduce GFR and increase plasma glycoside levels.</li><li>Lithium: There is evidence for potential increase in plasma levels of lithium.</li><li>Methotrexate: There is the potential for increased plasma levels of methotrexate.</li><li>Ciclosporin: Increased risk of nephrotoxicity.</li><li>Mifepristone: NSAIDs should not be used for 8-12 days after mifepristone administration as NSAIDs can reduce the effect of mifepristone.</li><li>Tacrolimus: Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus.</li><li>Zidovudine: There is evidence of an increased risk of haemarthroses and haematoma in HIV positive haemophiliacs receiving concurrent treatment with zidovudine and ibuprofen.</li></ul><p>Quinolone antibiotics: Animal data indicate that NSAIDs can increase the risk of convulsions associated with quinolone antibiotics. Patients taking NSAIDs and quinolones may have an increased risk of developing convulsions</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1-1-1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use during pregnancy</p><p>&nbsp;</p><p>Whilst no teratogenic effect has been demonstrated in animal experiments, use of ibuprofen during pregnancy should be avoided during the first 6 months of pregnancy.</p><p>During the third trimester, ibuprofen is contraindicated as there is a risk of premature closure of the foetal ductus arteriosus with possible persistent pulmonary hypertension. The onset of labour may be delayed and duration of labour increased with an increased bleeding tendency in both mother and child (see Section 4.3).</p><p>1-1-2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use during lactation</p><p>In limited studies, ibuprofen appears in the breast milk in very low concentrations, and is unlikely to affect the breast fed infant adversely</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None expected at recommended doses and duration of therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hypersensitivity reactions have been reported and these may consist of:</p><p>a) Non-specific allergic reactions and anaphylaxis,</p><p>b) Respiratory tract reactivity comprising asthma, aggravated asthma, bronchospasm or dyspnoea,</p><p>c) Various skin reactions, e.g. pruritus, urticaria, angioedema and more rarely, exfoliative and bullous dermatoses (including epidermal necrolysis and erythema multiforme).</p><p>&nbsp;</p><p>The list of the following adverse effects relates to those experienced with ibuprofen at OTC doses, from short-term use. In chronic conditions, under long-term treatment, additional adverse effects may occur. The most commonly-observed adverse events are gastrointestinal in nature.</p><p>&nbsp;</p><p><strong>Blood and lymphatic disorders</strong></p><p><u>Very rare:</u></p><p>Haematopoietic disorders (anaemia, hemolytic anemia, aplastic anemia), leucopenia, thrombocytopenia, pancytopenia, agranulocytosis). First signs are: fever, sore throat, superficial mouth ulcers, flu-like symptoms, severe exhaustion, nose and skin bleeding.</p><p>&nbsp;</p><p><strong>Immune system disorders</strong></p><p>&nbsp;</p><p><u>Uncommon:</u></p><p>Hypersensitivity reactions with urticaria and pruritus.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><u>Very rare:</u></p><p>In patients with existing auto-immune disorders (such as systemic lupus erythematosus, mixed connective tissue disease) during treatment with ibuprofen, single cases of symptoms of aseptic meningitis, such as stiff neck, headache, nausea, vomiting, fever or disorientation have been observed.</p><p>&nbsp;</p><p>Severe hypersensitivity reactions. Symptoms could be: facial, tongue and larynx swelling, dyspnoea, tachycardia, hypotension, (anaphylaxis, angioedema or severe shock).</p><p>&nbsp;</p><p>Exacerbation of asthma and bronchospasm.</p><p>&nbsp;</p><p><strong>Psychiatric disorders</strong></p><p><u>Very rare:</u></p><p>Nervousness</p><p><strong>&nbsp;</strong></p><p><strong>Nervous System</strong></p><p><u>Uncommon</u>:</p><p>Headache</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><u>Very rare:</u></p><p>Aseptic meningitis</p><p>&nbsp;</p><p><strong>Eye disorders</strong></p><p><u>Very rare:</u></p><p>Visual disturbance</p><p>&nbsp;</p><p><strong>Ear and labyrinth disorders</strong></p><p><u>Very rare:</u></p><p>Tinnitus and vertigo</p><p>&nbsp;</p><p><strong>Cardiac disorders</strong></p><p><u>Very rare:</u></p><p>Cardiac failure, angina pectoris</p><p>&nbsp;</p><p><strong>Vascular disorders</strong></p><p><u>Very rare:</u></p><p>Hypertension</p><p>&nbsp;</p><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p><p><u>Very rare:</u></p><p>Asthma, bronchospasm, dyspnoea and wheezing</p><p>&nbsp;</p><p><strong>Gastrointestinal disorders</strong></p><p><u>Uncommon:</u></p><p>Abdominal pain, abdominal distension, dyspepsia and nausea.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><u>Rare:</u></p><p>Diarrhoea, flatulence, constipation and vomiting</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><u>Very rare:</u></p><p>Peptic ulcer, perforation or gastrointestinal haemorrhage, melaena, haematemesis, sometimes fatal, particularly in the elderly (see section 4.4). Exacerbation of ulcerative colitis and Crohn&#39;s disease (see section 4.4). Mouth ulceration.</p><p>&nbsp;</p><p><strong>Hepatobiliary disorders</strong></p><p><u>Very rare:</u></p><p>Liver disorders, especially in long-term treatment, hepatitis and jaundice</p><p>&nbsp;</p><p><strong>Skin and subcutaneous tissue disorders</strong></p><p><u>Uncommon:</u></p><p>Various skin rashes</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><u>Very rare:</u></p><p>Severe forms of skin reactions such as bullous reactions, including Stevens-Johnson Syndrome, erythema multiforme and epidermal necrolysis can occur.</p><p>&nbsp;</p><p><strong>Renal and urinary disorders</strong></p><p><u>Very rare:</u></p><p>Acute renal failure, papillary necrosis, especially in long-term use, associated with increased serum urea and oedema. Haematuria, interstitial nephritis, nephritic syndrome, proteinuria.</p><p>&nbsp;</p><p><strong>General disorders and administration site conditions</strong></p><p><u>Very rare:</u></p><p>Oedema, peripheral oedema</p><p>&nbsp;</p><p><strong>Investigations</strong></p><p><strong>&nbsp;</strong></p><p><u>Very rare:</u></p><p>Decreased hematocrit and hemoglobin levels</p><p>Clinical studies suggest that use of ibuprofen, particularly at a high dose (&ge;2400mg/day) may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke) (see section 4.4).</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;To report any side effect (s):</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Saudi Arabia: National Pharmacovigilance &amp; Drug Safety Centre (NPC)</p><p>q&nbsp; Fax: +966-11-205-7662</p><p>q&nbsp; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>q&nbsp; Toll free phone: 8002490000</p><p>q&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>q&nbsp; Website: www.sfda.gov.sa/npc</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In children ingestion of more than 400mg/kg may cause symptoms. In adults the dose response effect is less clear cut. The half-life in overdose is 1.5-3 hours.</p><p><strong>Symptoms</strong></p><p>Most patients who have ingested clinically important amounts of NSAIDs will develop no more than nausea, vomiting, epigastric pain, or more rarely diarrhoea. Tinnitus, headache and gastrointestinal bleeding are also possible. In more serious poisoning, toxicity is seen in the central nervous system, manifesting as vertigo, headache, respiratory depression, dyspnoea, drowsiness, occasionally excitation and disorientation or coma. Occasionally patients develop convulsions. In serious poisoning, hypotension, hypokalaemia and metabolic acidosis may occur and the prothrombin time/INR may be prolonged, probably due to interference with the actions of circulating clotting factors. Acute renal failure and liver damage may occur. Exacerbation of asthma is possible in asthmatics.</p><p><strong>&nbsp;</strong></p><p><strong>Management</strong></p><p>Management should be symptomatic and supportive and include the maintenance of a clear airway and monitoring of cardiac and vital signs until stable. Consider oral administration of activated charcoal if the patient presents within 1 hour of ingestion of a potentially toxic amount. If frequent or prolonged, convulsions should be treated with intravenous diazepam or lorazepam. Give bronchodilators for asthma.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Propionic acid derivatives</p><p>&nbsp;ATC Code: &nbsp;M01AE</p><p>Ibuprofen is a phenylpropionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans, ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.</p><p>Single-dose clinical studies demonstrate that the pain relieving effects of ibuprofen liquigels are evident within around 30 minutes of dosing. The effects of a 400mg dose of ibuprofen liquigels are statistically superior to 1000mg paracetamol tablets both in the speed of onset and extent of analgesia. The differences in onset (see table below) are between 0.6 and 14 min. From the same studies, a single dose of 200mg did not show significant differences in onset of analgesia when compared to 1000mg paracetamol.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:596px"><tbody><tr><td style="vertical-align:top"><p>Clinical Parameters</p></td><td style="vertical-align:top"><p>Ibuprofen Liquigels</p><p>200mg</p></td><td style="vertical-align:top"><p>Ibuprofen Liquigels</p><p>400mg</p></td><td style="vertical-align:top"><p>Acetaminophen</p><p>1g (2 x 500mg)</p></td><td style="vertical-align:top"><p>Placebo</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p>Packman et al</p></td></tr><tr><td style="vertical-align:top"><p>Total Pain Relief (TOTPAR)</p></td><td style="vertical-align:top"><p>N/A</p></td><td style="vertical-align:top"><p>N/A</p></td><td style="vertical-align:top"><p>N/A</p></td><td style="vertical-align:top"><p>N/A</p></td></tr><tr><td style="vertical-align:top"><p>Sum of Pain Relief &amp; Pain Intensity Difference (SPID)</p></td><td style="vertical-align:top"><p>N/A</p></td><td style="vertical-align:top"><p>15.2</p></td><td style="vertical-align:top"><p>12.2</p></td><td style="vertical-align:top"><p>5.8</p></td></tr><tr><td style="vertical-align:top"><p>Time to Meaningful Relief (mins)</p></td><td style="vertical-align:top"><p>N/A</p></td><td style="vertical-align:top"><p>39</p></td><td style="vertical-align:top"><p>53</p></td><td style="vertical-align:top"><p>&gt;180</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p>Hersch et al</p></td></tr><tr><td style="vertical-align:top"><p>Total Pain Relief (TOTPAR)</p></td><td style="vertical-align:top"><p>14.72</p></td><td style="vertical-align:top"><p>16.56</p></td><td style="vertical-align:top"><p>11.99</p></td><td style="vertical-align:top"><p>5.25</p></td></tr><tr><td style="vertical-align:top"><p>Sum of Pain Relief &amp; Pain Intensity Difference (SPID)</p></td><td style="vertical-align:top"><p>6.93</p></td><td style="vertical-align:top"><p>8.07</p></td><td style="vertical-align:top"><p>5.05</p></td><td style="vertical-align:top"><p>0.46</p></td></tr><tr><td style="vertical-align:top"><p>Time to Meaningful Relief (mins)</p></td><td style="vertical-align:top"><p>30.0</p></td><td style="vertical-align:top"><p>28.8</p></td><td style="vertical-align:top"><p>29.4</p></td><td style="vertical-align:top"><p>&gt;360</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p>Olson et al</p></td></tr><tr><td style="vertical-align:top"><p>Total Pain Relief (TOTPAR)</p></td><td style="vertical-align:top"><p>N/A</p></td><td style="vertical-align:top"><p>17.42</p></td><td style="vertical-align:top"><p>13.30</p></td><td style="vertical-align:top"><p>4.33</p></td></tr><tr><td style="vertical-align:top"><p>Sum of Pain Relief &amp; Pain Intensity Difference (SPID)</p></td><td style="vertical-align:top"><p>N/A</p></td><td style="vertical-align:top"><p>11.77</p></td><td style="vertical-align:top"><p>8.36</p></td><td style="vertical-align:top"><p>2.60</p></td></tr><tr><td style="vertical-align:top"><p>Time to Meaningful Relief (mins)</p></td><td style="vertical-align:top"><p>N/A</p></td><td style="vertical-align:top"><p>24.2</p></td><td style="vertical-align:top"><p>29.9</p></td><td style="vertical-align:top"><p>&gt;360</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p>Kellstein et al</p></td></tr><tr><td style="vertical-align:top"><p>Total Pain Relief (TOTPAR)</p></td><td style="vertical-align:top"><p>36</p></td><td style="vertical-align:top"><p>30</p></td><td style="vertical-align:top"><p>N/A</p></td><td style="vertical-align:top"><p>52</p></td></tr><tr><td style="vertical-align:top"><p>Pain Intensity Difference (PID) after 2 hours</p></td><td style="vertical-align:top"><p>0.98</p></td><td style="vertical-align:top"><p>0.97</p></td><td style="vertical-align:top"><p>N/A</p></td><td style="vertical-align:top"><p>0.87</p></td></tr><tr><td style="vertical-align:top"><p>Time to Meaningful Relief (mins)</p></td><td style="vertical-align:top"><p>N/A</p></td><td style="vertical-align:top"><p>N/A</p></td><td style="vertical-align:top"><p>N/A</p></td><td style="vertical-align:top"><p>N/A</p></td></tr></tbody></table><p>Clinical evidence demonstrates that when 400 mg of ibuprofen are taken, pain relieving effects can last for up to 8 hours.</p><p>Experimental data suggest that ibuprofen may competitively inhibit the effect of low dose aspirin (acetylsalicylic acid) on platelet aggregation when they are dosed concomitantly. Some pharmacodynamics studies show that when single doses of ibuprofen 400mg were taken within 8 hours before or within 30 min after immediate release aspirin (acetylsalicylic acid) dosing (81 mg), a decreased effect of aspirin (acetylsalicylic acid) on the formation of thromboxane or platelet aggregation occurred. Although there are uncertainties regarding extrapolation of these data to the clinical situation, the possibility that regular, long-term use of ibuprofen may reduce the cardioprotective effect of low-dose aspirin (acetylsalicylic acid) cannot be excluded. No clinically relevant effect is considered to be likely for occasional ibuprofen use (see section 4.5).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ibuprofen is rapidly absorbed following administration and is rapidly distributed throughout the whole body. The excretion is rapid and complete via the kidneys. Compared to standard tablet formulations, ibuprofen administered in liquid-filled capsules reaches maximum plasma concentrations significantly faster. Peak plasma concentrations were achieved in around 35 minutes for liquigels compared to around 90 minutes for standard ibuprofen tablets.</p><p>The half life of ibuprofen is about 2 hours. In limited studies, ibuprofen appears in breast milk in very low concentrations.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No relevant information additional to that already contained is elsewhere in the SPC</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1-1&nbsp;&nbsp;&nbsp;&nbsp; List of excipients&nbsp;&nbsp;&nbsp;</p><p>q&nbsp; Polyethylene glycol 600</p><p>q&nbsp; Potassium Hydroxide 50% solution</p><p>q&nbsp; &nbsp;Anidrisorb 85/70</p><p>q&nbsp; Gelatin 150 Bloom EP.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store at temperature between 15-25&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>DOLORAZ</strong>&nbsp; 400 Soft Gelatin Capsules are packed in boxes of 20 Tablets blistered in Aluminium Foil Blisters.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p><p>Any unused product or waste material should be disposed of in accordance with local requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The Jordanian Pharmaceutical Manufacturing Co. Ltd.
PO Box 151
Um Al-Amad 16197
Jordan

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                October 2016.
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>